Authors:
DEBYSER Z
VANWIJNGAERDEN E
VANLAETHEM K
BEUSELINCK K
REYNDERS M
DECLERCQ E
DESMYTER J
VANDAMME AM
Citation: Z. Debyser et al., FAILURE TO QUANTIFY VIRAL LOAD WITH 2 OF THE 3 COMMERCIAL METHODS IN A PREGNANT WOMAN HARBORING AN HIV TYPE-1 SUBTYPE-G STRAIN, AIDS research and human retroviruses, 14(5), 1998, pp. 453-459
Authors:
ESTE JA
CABRERA C
SCHOLS D
CHEREPANOV P
GUTIERREZ A
WITVROUW M
PANNECOUQUE C
DEBYSER Z
RANDO RF
CLOTET B
DESMYTER J
DECLERCQ E
Citation: Ja. Este et al., HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN GP120 AS THE PRIMARY TARGETFOR THE ANTIVIRAL ACTION OF AR177 (ZINTEVIR), Molecular pharmacology, 53(2), 1998, pp. 340-345
Authors:
PARK K
DEBYSER Z
TABOR S
RICHARDSON CC
GRIFFITH JD
Citation: K. Park et al., FORMATION OF A DNA LOOP AT THE REPLICATION FORK GENERATED BY BACTERIOPHAGE-T7 REPLICATION PROTEINS, The Journal of biological chemistry, 273(9), 1998, pp. 5260-5270
Citation: Z. Debyser et al., COMPARATIVE-EVALUATION OF 3 ELISA TECHNIQUES AND AN INDIRECT IMMUNOFLUORESCENCE ASSAY FOR THE SEROLOGICAL DIAGNOSIS OF EPSTEIN-BARR-VIRUS INFECTION, Clinical and diagnostic virology, 8(1), 1997, pp. 71-81
Authors:
WITVROUW M
BALZARINI J
PANNECOUQUE C
JHAUMEERLAULLOO S
ESTE JA
SCHOLS D
CHEREPANOV P
SCHMIT JC
DEBYSER Z
VANDAMME AM
DESMYTER J
RAMADAS SR
DECLERCQ E
Citation: M. Witvrouw et al., SRR-SB3, A DISULFIDE-CONTAINING MACROLIDE THAT INHIBITS A LATE-STAGE OF THE REPLICATIVE CYCLE OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 262-268
Authors:
CHEREPANOV P
ESTE JA
RANDO RF
OJWANG JO
REEKMANS G
STEINFELD R
DAVID G
DECLERCQ E
DEBYSER Z
Citation: P. Cherepanov et al., MODE OF INTERACTION OF G-QUARTETS WITH THE INTEGRASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Molecular pharmacology, 52(5), 1997, pp. 771-780
Authors:
JONCKHEERE H
DEVREESE K
DEBYSER Z
VANDEKERCKHOVE J
BALZARINI J
DESMYTER J
DECLERCQ E
ANNE J
Citation: H. Jonckheere et al., A 2 PLASMID COEXPRESSION SYSTEM IN ESCHERICHIA-COLI FOR THE PRODUCTION OF VIRION-LIKE REVERSE-TRANSCRIPTASE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virological methods, 61(1-2), 1996, pp. 113-125
Authors:
JONCKHEERE H
DEVREESE K
DEBYSER Z
BALZARINI J
DESMYTER J
DECLERCQ E
Citation: H. Jonckheere et al., A COEXPRESSION SYSTEM FOR THE HETERODIMERIC REVERSE-TRANSCRIPTASE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN THE STUDY OF THE FUNCTIONALITY OF P51, THE SMALL-SUBUNIT OF HIV-1 RT, Journal of cellular biochemistry, 1995, pp. 192-192
Authors:
THORMAR H
BALZARINI J
DEBYSER Z
WITVROUW M
DESMYTER J
DECLERCQ E
Citation: H. Thormar et al., INHIBITION OF VISNA VIRUS-REPLICATION AND CYTOPATHIC EFFECT IN SHEEP CHOROID-PLEXUS CELL-CULTURES BY SELECTED ANTI-HIV AGENTS, Antiviral research, 27(1-2), 1995, pp. 49-57
Authors:
VANDAMME AM
DEBYSER Z
PAUWELS R
DEVREESE K
GOUBAU P
YOULE M
GAZZARD B
STOFFELS PA
CAUWENBERGH GF
ANNE J
ANDRIES K
JANSSEN PAJ
DESMYTER J
DECLERCQ E
Citation: Am. Vandamme et al., CHARACTERIZATION OF HIV-1 STRAINS ISOLATED FROM PATIENTS TREATED WITHTIBO R82913, AIDS research and human retroviruses, 10(1), 1994, pp. 39-46
Citation: Z. Debyser et al., COORDINATION OF LEADING AND LAGGING-STRAND DNA-SYNTHESIS AT THE REPLICATION FORK OF BACTERIOPHAGE-T7, Cell, 77(1), 1994, pp. 157-166
Authors:
DECLERCQ E
YAMAMOTO N
PAUWELS R
BALZARINI J
WITVROUW M
DEVREESE K
DEBYSER Z
ROSENWIRTH B
PEICHL P
DATEMA R
THORNTON D
SKERLJ R
GAUL F
PADMANABHAN S
BRIDGER G
HENSON G
ABRAMS M
Citation: E. Declercq et al., HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 668-674
Authors:
PAUWELS R
ANDRIES K
DEBYSER Z
KUKLA MJ
SCHOLS D
BRESLIN HJ
WOESTENBORGHS R
DESMYTER J
JANSSEN MAC
DECLERCQ E
JANSSEN PAJ
Citation: R. Pauwels et al., NEW YDROIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-ONE AND OIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-THIONE DERIVATIVES ARE POTENT INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION AND ARE SYNERGISTIC WITH 2',3'-DIDEOXYNUCLEOSIDE ANALOGS, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2863-2870
Authors:
THORMAR H
BALZARINI J
HOLY A
JINDRICH J
ROSENBERG I
DEBYSER Z
DESMYTER J
DECLERCQ E
Citation: H. Thormar et al., INHIBITION OF VISNA VIRUS-REPLICATION BY 2',3'-DIDEOXYNUCLEOSIDES ANDACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS, Antimicrobial agents and chemotherapy, 37(12), 1993, pp. 2540-2544
Authors:
DEBYSER Z
DEVREESE K
KNOPSGERRITS PP
BAEKELANDT V
BHIKHABHAI R
STRANDBERG B
PAUWELS R
ANNE J
DESMYTER J
DECLERCQ E
Citation: Z. Debyser et al., KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS, Molecular pharmacology, 43(4), 1993, pp. 521-526
Authors:
DEBYSER Z
PAUWELS R
ANDRIES K
DESMYTER J
ENGELBORGHS Y
JANSSEN PAJ
DECLERCQ E
Citation: Z. Debyser et al., ALLOSTERIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY HYDROIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE AND THIONE COMPOUNDS, Molecular pharmacology, 41(1), 1992, pp. 203-208